mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
NU-7441 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.076 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |